Literature DB >> 12679883

Pirarubicin is taken up by a uridine-transportable sodium-dependent concentrative nucleoside transporter in Ehrlich ascites carcinoma cells.

Katsuhito Nagai1, Kazuki Nagasawa, Atsushi Ishimoto, Sadaki Fujimoto.   

Abstract

PURPOSE: We evaluated the contribution of a nucleoside transporter (NT) consisting of an equilibrative NT (ENT) and a concentrative Na(+)/nucleoside cotransporter (CNT) to the uptake of THP and DOX by mouse Ehrlich ascites carcinoma cells. METHODS. Transport experiments were performed using a silicone layer method. The expression of CNT isoforms was confirmed by RT-PCR analysis.
RESULTS: The effects of inhibition of the ENT inhibitors, nitrobenzylthioinosine (NBMPR) and nitrobenzylthioguanosine, on THP and DOX uptake by Ehrlich cells was negligible. THP uptake, but not DOX uptake, partially depended on an inwardly directed Na(+) gradient, and the uptake was inhibited by all the inhibitors of CNT examined. Furthermore, efflux of [(3)H]uridine from Ehrlich cells was stimulated by the addition of THP to the extracellular compartment, which was definitive evidence of CNT-mediated uptake of THP. The mRNA for CNT2, but not that for CNT3, was detected in Ehrlich cells, which is consistent with the characteristics of [(3)H]uridine uptake. In the cells, formycin B, a representative CNT2 ligand, had cis-inhibitory and trans-stimulatory effects on THP uptake.
CONCLUSION: These results demonstrate that THP, but not DOX, is taken up into Ehrlich cells partially via a uridine-transportable CNT.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12679883     DOI: 10.1007/s00280-003-0569-0

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  2 in total

1.  HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases.

Authors:  Haruhiko Dozono; Shintaro Yanazume; Hideaki Nakamura; Tomáš Etrych; Petr Chytil; Karel Ulbrich; Jun Fang; Takeshi Arimura; Tsutomu Douchi; Hiroaki Kobayashi; Michiaki Ikoma; Hiroshi Maeda
Journal:  Target Oncol       Date:  2016-02       Impact factor: 4.493

2.  Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) mice.

Authors:  Aaron M Moss; Christopher J Endres; Ana Ruiz-Garcia; Doo-Sup Choi; Jashvant D Unadkat
Journal:  Mol Pharm       Date:  2012-08-03       Impact factor: 5.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.